Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Nakamura (Hamamatsu, Japan), K. Mori (Hamamatsu, Japan), Y. Enomoto (Hamamatsu, Japan), M. Kono (Hamamatsu, Japan), H. Sumikawa (Osaka, Japan), T. Johkoh (Hyogo, Japan), T. Colby (Scottsdale, AZ, United States of America), H. Yasui (Hamamatsu, Japan), H. Hozumi (Hamamatsu, Japan), M. Karayama (Hamamatsu, Japan), Y. Suzuki (Hamamatsu, Japan), K. Furuhashi (Hamamatsu, Japan), T. Fujisawa (Hamamatsu, Japan), N. Enomoto (Hamamatsu, Japan), N. Inui (Hamamatsu, Japan), Y. Kaida (Hamamatsu, Japan), K. Yokomura (Hamamatsu, Japan), N. Koshimizu (Fujieda, Shizuoka, Japan), M. Toyoshima (Hamamatsu, Japan), S. Imokawa (Iwata, Shizuoka, Japan), T. Yamada (Shizuoka, Japan), T. Shirai (Shizuoka, Japan), H. Nakamura (Hamamatsu, Japan), H. Hayakawa (Hamamatsu, Japan), T. Suda (Hamamatsu, Japan). Prognostic and clinical value of cluster analysis of idiopathic pleuroparenchymal fibroelastosis phenotypes. 1928

Member's Comments

No comment yet.

Related content which might interest you: The significance of serum biomarkers as predictive factors for the clinical course of idiopathic pleuroparenchymal fibroelastosis (IPPFE) Source: International Congress 2017 – Rare diseases Year: 2017 Pleuroparenchymal fibroelastosis - clinical analysis of 22 cases Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Prognostic significance of clinical and morphological features in idiopathic interstitial pneumonias Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002 Clinical and pathological features of idiopathic and secondary pleuroparenchymal fibroelastosis in patients undergoing lung transplantation Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Clinical value of cluster analysis of unclassifiable idiopathic interstitial pneumonias phenotypes Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis? Year: 2020 Prognostic evaluation in Chinese patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Clinical courses of asymptomatic patients with mild idiopathic pleuroparenchymal fibroelastosis Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Clinical and prognostic value of atrial natriutic peptide in patients with idiopathic pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006 Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Prognostic evaluation in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 The prognostic significance of fibroblastic foci in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 The health status in idiopathic pleuroparenchymal fibroelastosis Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Prognostic value of SVC change in fibrotic idiopathic interstitial pneumonia Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Prognostic value of modified classification based on lung function tests in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006 Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes Source: Eur Respir J 2012; 40: 377-385 Year: 2012 Idiopathic pulmonary fibrosis: Clinical, radiological and functional significance of biomarkers of proliferation Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Prognostic factors affecting survival of idiopathic pulmonary fibrosis in Korean population Source: Eur Respir J 2007; 30: Suppl. 51, 578s Year: 2007 Dyspnoea: a prognostic marker for idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 37: 476 Year: 2011 A novel prognostic signature based on five-immune-related genes for idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021 Prognostic factors of idiopathic pulmonary fibrosis diagnosed by surgical lung biopsy Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009